Appendices Age



Download 9.01 Kb.
Date conversion19.11.2016
Size9.01 Kb.
Appendices




Age

PSA

Stage

Gleason Score

Primary disease location

6 month PSA

6 month MRI

7 month biopsy

Location of residual disease

Treatment

Patient 1

57

19

T2A

3+4

Right anterior

5.9

Central/left anterior mid transition zone nodule. Also suspicious changes in left mid-zone laterally.

Gleason 3+4 at right posterior apex (0.75mm of core involved), Gleason 3+3 at left anterior (6.8mm of core involved). 9 of 42 cores positive.

Adjacent

Active surveillance

Patient 2

62

4.6

T1C

3+4

Right anterior apex and right transitional zone

2

Persistent tumour at right anterior apex

Gleason 4+4 at right anterior location (0.4mm of core involved). 5 of 25 cores positive

Adjacent

Awaiting repeat IRE

Patient 3

73

7.6

T1C

3+4

Left mid postero-lateral and left transitional zone

7.6

Residual 7mm nodule of tumour in left mid zone

Gleason 4+3 at left mid postero-lateral (3.5mm of core involved), Gleason 3+4 at left posterior apex (0.65mm of core involved) and left base postero-lateral (0.8mm of core involved). 4 of 29 cores positive

Adjacent

Active Surveillance

Patient 4

67

5.9

T1C

3+4

Anterior apex and base on right side and in midline

2.9

12mm residual tumour inferior to ablated area at anterior apex

Gleason 3+4 at right anterior apex (2 cores, 15mm of longest core involved) and left anterior (3.3mm of core involved). 6 of 27 cores positive.

Adjacent

Radical prostatectomy

Patient 5

68

6.1

T2A

3+4

Right anterolateral apex

5.6

Nil residual tumour

Gleason 3+4 at right base posterior (2mm of core involved). 2 of 26 cores positive.

Outfield

Active surveillance

Appendix 1: Summary of patients with significant disease on follow up biopsy


The database is protected by copyright ©dentisty.org 2016
send message

    Main page